Haku

Hakusi sanalla 'medicinering' tuotti 257 tulosta
Fess-haku
  1. Individualiserad medicin främjar hälsa och välfärd Individualiserad medicin främjar individens hälsa och välfärd genom utnyttjande av forskning, ny teknik och större informationsresurser än tidigare. Målet är att förebygga sjukdomar och förbättra ...
    https://stm.fi/sv/individualiserad-medicin
  2. fi sv en Personalised medicine creates preconditions for more effective treatment Personalised medicine promotes the health and wellbeing of individuals by utilising research, new technologies and a wider range of information resources. The aim is...
    https://stm.fi/en/personalized-medicine
  3. Biotechnology and Medicines Unit (BILA) - personnel Hidden
    https://stm.fi/en/bila-personnel
  4. Project on medicines and financial base of pharmacies The Government Programme includes numerous entries related to medicines and pharmacies. These entries will be implemented in a project titled ‘Medicines and the financial base of pharmacies’ in...
    https://stm.fi/en/reform-of-pharmaceutical-matters
  5. 1.12.2025 | The EU ministers will attend the Employment, Social Policy, Health and Consumer Affairs Council in Brussels on 1 and 2 December 2025. On both days, Finland will be represented by Minister of Social Affairs and Health Kaisa Juuso.
    https://stm.fi/en/-/eu-ministers-to-discuss-carcinogens-and-mutagens-directive-critical-medicines-simplification-of-legislation-and-european-globalisation-adjustment-fund
  6. 23.4.2024 | The health ministers of the EU Member States will discuss the availability of healthcare personnel and medicines at their informal meeting in Brussels on 23–24 April. 
    https://stm.fi/en/-/eu-ministerial-meeting-on-healthcare-personnel-and-medicine-availability
  7. 3.10.2024 | According to a working group appointed by the Ministry of Social Affairs and Health, the sale of some over-the-counter medicines could be expanded outside pharmacies if the change is made in a controlled manner, ensuring medication safety. The change could improve the availability of over-the-counter medicines and reduce the costs of medicines for consumers and society.
    https://stm.fi/en/-/working-group-the-sale-of-over-the-counter-medicines-outside-pharmacies-should-be-implemented-in-a-controlled-and-systematic-manner
  8. 3.5.2023 | An informal meeting of EU employment and social affairs ministers will take place in Stockholm on 3–4 May 2023 and an informal meeting of EU health ministers on 4–5 May 2023. Minister of Social Affairs and Health Hanna Sarkkinen and Minister of Family Affairs and Social Services Krista Kiuru will represent Finland at the meetings.
    https://stm.fi/en/-/eu-ministers-meet-to-discuss-access-to-medicinal-products-skills-in-working-life-and-eu-social-dimension-
  9. 29.11.2023 | At the beginning of 2023, an amendment to the Decree on Prescribing Medicines entered into force whereby prescriptions for all biological medicines are valid for one year. People using biological medicines should check the validity of their prescriptions with their attending physician or the pharmacy.
    https://stm.fi/en/-/prescriptions-for-biological-medicines-are-only-valid-for-one-year-at-a-time
  10. 30.11.2023 | The EU health ministers will meet in Brussels on Thursday 30 November 2023. The ministers will exchange views on safeguarding the EU’s open strategic autonomy in the field of health, particularly on how to ensure the availability of medicines in Europe. They will also approve conclusions on mental health. Minister of Social Security Sanni Grahn-Laasonen will represent Finland at the meeting.
    https://stm.fi/en/-/eu-health-ministers-to-discuss-steps-to-ensure-access-to-medicines-
  11. According to the Ministry of Social Affairs and Health Decree on the prescription of medicines (1088/2010), special attention must be given to the safety of pharmaceuticals.
    https://stm.fi/en/legislation-steering-and-supervision-cooperation
  12. Value chain for pharmacotherapy Pharmaceuticals-related development, research and innovations The facilitation of research and development of pharmaceuticals is a requirement for new pharmaceutical innovations. It is characteristic of the pharmace...
    https://stm.fi/en/value-chain-for-pharmacotherapy
  13. Rational, or sensible, pharmacotherapy is effective, safe, of high quality, economical and equal.
    https://stm.fi/en/rational-pharmacotherapy
  14. Pharmacotherapy and pharmaceutical service The Ministry of Social Affairs and Health is responsible for the development of pharmaceutical services and for preparation of legislation on pharmaceuticals. Pharmaceutical services are an integral part ...
    https://stm.fi/en/pharmacotherapy
  15. Safety of pharmacotherapy Pharmacotherapy is an integral part of comprehensive care. At its best, pharmacotherapy can cure illnesses, slow the progression of illnesses, reduce the symptoms of illnesses and prevent illnesses. Safe pharmacotherapy c...
    https://stm.fi/en/safety-of-pharmacotherapy
  16. Electronic services support the pharmacotherapy Medication list as a tool for healthcare professionals A national up-to-date medication list is under preparation. Its benefits will be based on a procedure where all essential structural medication ...
    https://stm.fi/en/rational-pharmacotherapy/digital-services
  17. Department for Safety, Security and Health The Department for Safety, Security and Health handles issues pertaining to: organising environmental healthcare and health protection alcohol, tobacco and drug policy and the prevention of harm caused by...
    https://stm.fi/en/department-for-safety-security-and-health
  18. Narcotics control The central framework for narcotics legislation in Finland is based on the Narcotics Act (373/2008). In the Narcotics Act two types of substances are defined that are listed in corresponding Government degrees. ‘Narcotics’ are li...
    https://stm.fi/en/narcotics-control
  19. 18.8.2020 | The Ministry of Social Affairs and Health has decided to temporarily restrict the sale and release for consumption of medicinal products containing paracetamol or dexamethasone. The restrictions will enter into force on 18 August 2020 and will remain in force until 15 January 2021.
    https://stm.fi/en/-/restrictions-on-the-sale-of-medicinal-products-containing-paracetamol-or-dexamethasone-to-ensure-their-availability-and-sufficiency
  20. Sickness and rehabilitation All people living in Finland are included within the scope of sickness insurance. Sickness insurance provides reimbursements for loss of earnings and costs of rehabilitation. Sickness (Kela) Sickness allowance Paid to 1...
    https://stm.fi/en/income-security/sickness-rehabilitation
  21. fi sv en National Genome Centre Data on people's genetic makeup helps make better personalised choices, target the screening of diseases, specify diagnostics, and choose the best and most effective treatment. In Finland, the development of persona...
    https://stm.fi/en/genome-center
  22. Frequently asked questions about the operating models and division of duties of healthcare and social welfare personnel This page contains frequently asked questions about the operating models and division of duties of healthcare and social welfar...
    https://stm.fi/en/social-and-health-care-personnel/faq
  23. EU collaboration project to promote access to genomic data The success of the European ‘1+ Million Genomes’ Initiative relies on wide-ranging collaboration. Among the objectives of the EU project is to ensure secure, cross-border access to genomic...
    https://stm.fi/en/european-1-million-genomes-initiative
  24. Genomcentret Genetisk information möjliggör bättre individuella val, riktade screeningar av sjukdomar, preciserade diagnoser och val av den effektivaste behandlingen. Utvecklingen av individualiserad medicin (engelska precision medicine eller pers...
    https://stm.fi/sv/genomcentret
  25. Ministry of Social Affairs and Health Minister of Social Security Sanni Grahn-Laasonen The National Coalition Party Minister of Social Security Sanni Grahn-Laasonen is responsible for matters covered by the Department for Insurance and Social Secu...
    https://stm.fi/en/minister-of-social-security
  26. Department for Insurance and Social Security The Department for Insurance and Social Security directs and steers insurance policy and is responsible for drafting social insurance and other insurance legislation. The Department handles issues that ...
    https://stm.fi/en/department-for-insurance-and-social-security-svo-
  27. fi sv en Overall project description The projects to improve the effective utilization of personalised medicines are linked to former Government’s key project of strengthening competitiveness. In the General Government Fiscal Plan, the Government ...
    https://stm.fi/en/personalized-medicine/overall-project-description
  28. fi sv en Improving health through the use of genomic data In the next few years, the use of genomic data in healthcare will rapidly increase. In the future, decisions regarding the prevention and treatment of diseases will be increasingly based on...
    https://stm.fi/en/genomicdata
  29. Tillväxt genom innovation och forskning inom hälsobranschen Målsättningarna inom projektet för individualiserad medicin förutsätter åtgärder inom lagstiftningen, datasystemen, datalagren och hälsovården. En förutsättning för att hälsovårdens datal...
    https://stm.fi/sv/beskrivning-av-projektet
  30. Regeringens proposition till riksdagen med förslag till lagstiftning om utveckling av apoteksverksamheten Regeringens proposition om utveckling av apoteksverksamheten Regeringens proposition till riksdagen med förslag till lagstiftning om utveckli...
    https://stm.fi/sv/projekt?tunnus=STM045:00/2025
  31. COVID-19 disease in Finland Shortly Since July 2023, COVID-19 has been classified as a monitored communicable disease instead of a generally hazardous communicable disease. Vaccinations continue to be the most important way to protect against seri...
    https://stm.fi/en/covid-19-disease-in-finland
  32. fi sv en Finnish Cancer Center FICAN The Finnish Cancer Center (FICAN) was established in 2019 to promote effective and equitable cancer care in Finland. FICAN’s mission is to implement the tasks defined in the Government Decree on the Division of...
    https://stm.fi/en/personalized-medicine/national-cancer-center
  33. Amending the Act on the Secondary Use of Health and Social Data The Ministry of Social Affairs and Health is preparing a government proposal for amending the Act on the Secondary Use of Health and Social Data (555/2019). The Act will be amended in...
    https://stm.fi/en/amending-the-act-on-the-secondary-use-of-health-and-social-data
  34. Government branch The administrative branch of the Ministry of Social Affairs and Health includes several independent institutions and agencies, which implement the ministry’s objectives in society and participate in Government Programme projects....
    https://stm.fi/en/administrative-branch
  35. Guidance of information management in healthcare and social welfare The Ministry of Social Affairs and Health is responsible for the general planning, guidance and monitoring of information management within its administrative branch and for the f...
    https://stm.fi/en/social-and-health-services/information-management
  36. Secondary use of health and social data A separate law has be laid down on the secondary use of health and social data (Act on the Secondary Use of Health and Social Data). The purpose of the Act is to facilitate the effective and safe processing ...
    https://stm.fi/en/secondary-use-of-health-and-social-data
  37. Informationshantering som stöd för rationell läkemedelsbehandling Med lösningar inom informationshantering och digitala tjänster kan man stödja läkemedelsbehandlingars säkerhet, kvalitet, ekonomi och jämlikhet, samt på lång sikt också deras effekt...
    https://stm.fi/sv/informationshantering
  38. Rokotukset Rokotukset ovat tärkeä osa yleistä tartuntatautien torjuntaa. Suomessa kaikille lapsille tarjotaan maksuttomia rokotteita sosiaali- ja terveysministeriön (STM) yhteistyössä asiantuntijoiden kanssa laatiman kansallisen rokotusohjelman mu...
    https://stm.fi/rokotukset
  39. EU-samarbetsprojekt främjar användningen av genomdata EU-projektet 1+ Million Genomes utmanar hela Europa och förutsätter ett brett samarbete för att lyckas. Detta EU-projekt har som mål att genom samarbete skapa en möjlighet att använda genomdata...
    https://stm.fi/sv/eu-projektet-1-million-genomes
  40. Implementation of sensible pharmacotherapy Service organisers are responsible for ensuring that residents have access to the necessary social and health care services. It is essential for service organisers and providers to ensure the implementati...
    https://stm.fi/en/rational-pharmacotherapy/implementation-of-sensible-pharmacotherapy
  41. Contact information Communications Unit / VIE Communications Unit / VIE Iina Bister, Communications Specialist Communications Unit / VIE Address Meritullinkatu 8, 00170 Helsinki Phone number +358295163015 Email [email protected] Mariina Cervera Li...
    https://stm.fi/en/browse-by-department-and-unit
  42. Drug policy Finland makes use of social policy, national legislation and international agreements to prevent the demand and supply of drugs reduce the harm caused by drugs ensure that people with drug problems receive treatment as early as possibl...
    https://stm.fi/en/drug-policy
  43. Council of Europe The areas of cooperation of the Ministry of Social Affairs and Health in the Council of Europe (CoE) include: Roma issues the rights of persons with disabilities children’s rights drug policy bioethics quality of medicines gender...
    https://stm.fi/en/international-cooperation/coe
  44. Vaccinationer Social- och hälsovårdsministeriet svarar för lagstiftningen om vaccinationsprogrammet och vaccin. Dessutom gör ministeriet en framställning till statsrådet och riksdagen om införande av nya vacciner i vaccinationsprogrammet samt besl...
    https://stm.fi/sv/vaccinationer
  45. fi sv en Biobank activities will be harmonised Biobanks are part of the research infrastructure. In biobanks, samples of human origin and related data are stored for supporting research. Biobanks operate in Finland in connection with hospital dist...
    https://stm.fi/en/personalized-medicine/biobank-operations
  46. Amended legislation on health checks for children and young adults Type: Press release Categories: Publication date: 22.12.2025 Request for comments: Legislative amendment would extend right of small alcohol producers to sell their products direct...
    https://stm.fi/en/news
  47. Regeringens proposition till riksdagen med förslag till lagstiftning om en reform av apoteksekonomin Regeringens proposition om apoteksekonomi Regeringens proposition till riksdagen med förslag till lagstiftning om en reform av apoteksekonomin STM...
    https://stm.fi/sv/projekt?tunnus=STM044:00/2025
  48. Further information fi sv en Drug Development Centre to promote competitive development of drugs Finland has competitive basic medical research of high quality that has the potential of developing new medicinal products. However, so far commercial...
    https://stm.fi/en/personalized-medicine/drug-development-centre
  49. Statutory insurance A significant part of social security in Finland is provided through statutory insurances. This package is called social insurance. The insurance-based forms of social security include earnings-related pension, occupational acc...
    https://stm.fi/en/statutory-insurance
  50. Information management to support rational pharmacotherapy Information management solutions and digital services can support the safety, quality, economy and equality of pharmacotherapy and, in the long term, the effectiveness of pharmacotherapy. ...
    https://stm.fi/en/rational-pharmacotherapy/information-management
  51. Health services The aim of healthcare in Finland is to maintain and improve people's health, wellbeing, work ability and functional capacity and social security, as well as to reduce inequalities in health. The healthcare system is based on preven...
    https://stm.fi/en/health-services
  52. World Health Organization The World Health Organization (WHO) is Finland’s most important international partner in the development and evaluation of health policy in Finland and globally. Finland is an active participant in global health policy an...
    https://stm.fi/en/international-cooperation/who
  53. Geeniteknologian säätely Sosiaali- ja terveysministeriö ohjaa ja valvoo geeniteknologian käyttöä yleisesti sekä erityisesti terveyteen liittyvissä kysymyksissä. Geeniteknologia on biotekniikkaa, joka pyrkii muuntamaan eliön perintötekijöitä tietty...
    https://stm.fi/geeniteknologia
  54. Enligt social- och hälsovårdsministeriets förordning om förskrivning av läkemedel (1088/2010) ska vid medicinering särskilt beaktas medicineringens säkerhet.
    https://stm.fi/sv/forfattningar-styrning-och-tillsyn-samarbete
  55. Kansallinen syöpäkeskus Kansallinen syöpäkeskus FICAN perustettiin vuonna 2019 edistämään vaikuttavaa ja yhdenvertaista syövän hoitoa Suomessa. Kansallinen syöpäkeskus toteuttaa keskittämisasetuksen (valtioneuvoston asetus erikoissairaanhoidon työ...
    https://stm.fi/syopakeskus
  56. Arbetsgruppen för att frigöra vissa egenvårdsläkemedel för försäljning på andra ställen än apotek STM093:00/2024 Projekt Detta kan bara vara partiella uppgifter. Om du vill ha alla uppgifter om projektet, var god och öppna sidan på finska. Projekt...
    https://stm.fi/sv/projekt?tunnus=STM093:00/2024
  57. Hemsjukvård och hemsjukhusvård Med hemsjukvård stöds patientens möjligheter att klara sig hemma och med hemsjukhusvård patientens möjlighet att stanna hemma som ett alternativ till sjukhusvård. Att främja människors möjligheter att bo kvar hemma o...
    https://stm.fi/sv/hemsjukvard-och-hemsjukhusvard
  58. Department for Clients and Services in Healthcare and Social Welfare The Department for Clients and Services in Healthcare and Social Welfare prepares and develops issues pertaining to the position and rights of the customer and the patient, healt...
    https://stm.fi/en/department-for-clients-and-services-in-healthcare-and-social-welfare
  59. Försäkringsläkare En försäkringsläkare är en expert inom medicin som arbetar vid en socialförsäkringsanstalt eller vid ett försäkringsbolag. Försäkringsläkaren fattar beslut om ansökningar om förmåner och ersättningar tillsammans med andra experte...
    https://stm.fi/sv/forsakringslakare
  60. Reglering av genteknologi Social- och hälsovårdsministeriet styr och övervakar tillämpningen av genteknologi i allmänhet och i hälsofrågor i synnerhet. Genteknologi är bioteknik som genom genteknik strävar efter att ändra organismers gener för vis...
    https://stm.fi/sv/genteknik
  61. Projektet inom apoteksekonomi och läkemedelsdistribution Genom projektet inom apoteksekonomi och läkemedelsdistribution fortsätter man det långsiktiga utvecklandet av helheten av läkemedelsärenden över regeringsperioderna. Syftet med reformen är a...
    https://stm.fi/sv/reform-av-lakemedelsarenden
  62. EU:n yhteistyöhanke edistää genomitiedon käyttöä EU:n 1+Million Genomes on suuri Euroopan laajuinen aloite, jonka onnistumisen edellytys on laaja yhteistyö. Aloitteen tavoitteena on luoda jäsenmaiden yhteistyönä mahdollisuus tietoturvalliseen ja y...
    https://stm.fi/yksilollistetty-laaketiede/euhanke1million-genomes
  63. Nationella cancercentret Det nationella cancercentret FICAN inrättades år 2019 för att främja effektiv och jämlik cancervård i Finland. Nationella cancercentret sköter de uppgifter som avses i centraliseringsförordningen (582/2017 statsrådets föro...
    https://stm.fi/sv/cancercentret
  64. Client and patient safety The safety of care and services is part of the overall quality of healthcare and social welfare. Safe care and services are evidence-based and effective. They are provided in the right way and at the right time. Client an...
    https://stm.fi/en/client-and-patient-safety
  65. Yksilöllistetty lääketiede luo edellytyksiä vaikuttavammalle hoidolle Yksilöllistetty lääketiede edistää yksilön terveyttä ja hyvinvointia hyödyntämällä tutkimusta, uusia teknologioita ja entistä laajempia tietovarantoja. Tavoitteena on ehkäistä s...
    https://stm.fi/yksilollistetty-laaketiede
  66. Support and benefits The Finnish social protection system includes various forms of financial support and benefits designed to ensure that everyone has an equal opportunity to take part in working life and society in general. Children and parentho...
    https://stm.fi/en/income-security/benefits
  67. Advisory Board on Biotechnology The Advisory Board on Biotechnology is an expert body providing advice on matters related to biotechnology and gene technology. It promotes cooperation between public authorities and researchers and operators in the...
    https://stm.fi/en/advisory-board-on-biotechnology
  68. Frequently asked questions about the Act on Secondary Use of Health and Social Data Usein kysyttyä: The law mentions the primary and secondary use of customer data. What is the difference between these two concepts? The primary use of customer dat...
    https://stm.fi/en/frequently-asked-questions-about-the-act-on-secondary-use-of-health-and-social-data
  69. Legislation on services and benefits for older people This page lists the key pieces of legislation on services and benefits for older people. Below you will find them by topic and also links to more detailed guidance. Health and social services I...
    https://stm.fi/en/old-people
  70. Whistleblower protection Whistleblower protection safeguards people who report certain types of misconduct. In this case, a ‘whistleblower’ is a person who, in the course of their work, discovers a breach of European Union or national law concerni...
    https://stm.fi/en/whistleblower-protection
  71. Med rationell läkemedelsbehandling avses att läkemedelsbehandlingen har god effekt, att den är säker, av hög kvalitet och kostnadseffektiv och att den ges till alla på lika villkor.
    https://stm.fi/sv/lakemedelsersattning/rationell-lakemedelsbehandling
  72. The Ministry of Social Affairs and Health directs, monitors and coordinates preparedness for incidents and emergencies in healthcare and social welfare.
    https://stm.fi/en/preparedness
  73. Ofta frågat Vad är en försäkringsläkare? En försäkringsläkare är en expert inom medicin som arbetar vid en socialförsäkringsanstalt eller vid ett försäkringsbolag. Dessutom kan med försäkringsläkare avses en läkare som behandlar försäkringsärenden...
    https://stm.fi/sv/ofta-fragat
  74. Organdonationer och transplantationer av organ och vävnader Målet i organdonations- och transplantationsverksamhet är att alla de patienter som på grund av sin sjukdom eller enligt en medicinsk bedömning skulle ha nytta av en organtransplantation ...
    https://stm.fi/sv/organ-och-vavnadstransplantationer
  75. Client charges in healthcare and social welfare The Government guides and directs the policy on client charges in healthcare and social welfare through legislation. The purpose of the policy is to ensure that the charges are kept at a reasonable l...
    https://stm.fi/en/client-fees
  76. Healthcare and social welfare system and responsibilities Finland’s healthcare and social welfare system is founded on public healthcare and social welfare services funded from tax revenue. Alongside the public sector, private companies provide he...
    https://stm.fi/en/pandemic-preparedness
  77. Läkemedelsbehandlingens värdekedja Läkemedelsutveckling, läkemedelsforskning och innovationer En förutsättning för att nya läkemedelsinnovationer ska kunna uppstå är att det är möjligt att bedriva läkemedelsforskning och läkemedelsutveckling. Läke...
    https://stm.fi/sv/lakemedelsbehandlingens-vardekedja
  78. 21.4.2026 | Social- och hälsovårdsministeriet begär utlåtanden om regeringens proposition om apotek med syftet att bland annat förtydliga innehållen i apotekstjänsterna, utveckla tillståndssystemet för apoteksverksamheten och främja e-tjänsterna inom apoteksverksamheten. Utlåtanden kan lämnas in under perioden 21.4–1.6.2026.
    https://stm.fi/sv/-/pa-remiss-lagen-andras-for-att-utveckla-och-fortydliga-apoteksverksamheten
  79. Healthcare and social welfare system and responsibilities Finland’s healthcare and social welfare system is founded on public healthcare and social welfare services funded from tax revenue. Alongside the public sector, private companies provide he...
    https://stm.fi/en/social-and-health-services/responsible-agencies
  80. Social- och hälsovård för papperslös I Finland vistas personer vars rätt till offentliga social- och hälsovårdstjänster är begränsad. I vardagligt tal använder man den allmänna benämningen papperslösa personer om dem. Papperslösheten definieras på...
    https://stm.fi/sv/halsovard-for-papperslosa
  81. Healthcare and social welfare for undocumented persons When it comes to the organisation of healthcare and social welfare, it should be noted that there are people residing both legally and illegally in Finland who are usually referred to as undoc...
    https://stm.fi/en/healthcare-and-social-welfare-for-undocumented-persons
  82. Preparation of EU matters Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) The EPSCO Council, which brings together ministers from all EU Member States, decides on EU cooperation in employment, social policy, health, consumer...
    https://stm.fi/en/international-cooperation/eu/preparation-of-eu-affairs
  83. 7.4.2026 | Social- och hälsovårdsministeriet begär utlåtanden om utkastet till regeringens proposition om utvecklandet av psykoterapiutbildningen. Syftet är att förbättra tillgången till psykoterapiutbildning genom att ändra den till en tvåstegsutbildning där den första delen kan vara avgiftsfri för de som har lämplig bakgrundsutbildning.
    https://stm.fi/sv/-/utkastet-till-propositionen-om-psykoterapiutbildningen-pa-remiss
  84. Lääkehoidon arvoketju Lääkekehitys, -tutkimus ja innovaatiot Lääketutkimuksen ja -kehityksen mahdollistaminen ovat edellytyksiä uusien lääkeinnovaatioiden syntymiselle. Lääketeollisuudelle on ominaista monivuotinen prosessi lääkekeksinnöstä valmii...
    https://stm.fi/laakehoidon-arvoketju
  85. 13.2.2026 | Together Against Cancer – Human-Centred Cancer Prevention and Care National Cancer Strategy 2026–2035 Finland National Cancer Strategy 2026–2035 Contents Summary 3 Strategic objectives 5 Current situation and operating environment 6 Cancer in Finl...
    https://stm.fi/documents/1271139/1329769/National_Cancer_Strategy_2026-2035_Finland.pdf/a29aa994-91bb-2bcd-e90e-a3d3fde32b90?t=1770968783502
  86. Amended legislation on health checks for children and young adults Categories: Publication date: 22.12.2025 The timing and content of health checks at child health clinics and schools, and in student healthcare and oral healthcare will be regulate...
    https://stm.fi/en/press-releases
  87. Social assistance Shortly Social assistance is a last-resort form of social security that secures the essential livelihood for an individual or a family when they cannot support themselves with other income or assets. It is a means-tested benefit,...
    https://stm.fi/en/income-security/social-assistance
  88. 6.10.2025 | Preparedness and data-driven decision-making in the field of pharmaceuticals were the key topics of discussion at a conference organised by Finland in Helsinki on 30 September–1 October 2025 as part of its Presidency of the Nordic Council of Ministers.
    https://stm.fi/en/-/nordic-pharmaceutical-conference-brings-together-experts-in-helsinki-to-discuss-preparedness
  89. 13.2.2026 | Reformen för att integrera apoteksverksamheten i social- och hälsovårdstjänsterna framskrider snabbt. Utvecklingen förutsätter att informationsgången fungerar bra, att tillgången till hälsouppgifterna säkerställs och att nya verksamhetssätt tas i användning. Utvecklingsarbetet sker inom projektet inom apoteksekonomi och läkemedelsdistribution, där man färdigställt verksamhetsmodellerna för hur apoteksverksamheten ska utvecklas under de kommande åren.
    https://stm.fi/sv/-/informationsgangen-ar-karnan-i-reformen-av-apoteksverksamheten
  90. 13.5.2020 | The Ministry of Social Affairs and Health has decided to extend the validity of decisions made under section 87 of the Emergency Powers Act. The aim is to ensure the availability of medicinal products and the functioning of the pharmaceutical supply chain in Finland. The content of the decisions is the same as of the decisions issued by the Ministry on 19 March 2020 and on 9 April 2020.
    https://stm.fi/en/-/valmiuslain-mukaisten-paatosten-voimassaoloa-jatketaan-laakevalmisteiden-saatavuuden-varmistamiseksi
  91. Legislation on termination on pregnancy
    https://stm.fi/en/termination-of-pregnancy
  92. Utkomststöd Kortfattat Utkomststödet är den form av social trygghet som blir aktuell i sista hand. Det tryggar en persons eller familjs oundgängliga försörjning, när övriga inkomster och tillgångar inte räcker till. Stödet är behovsprövat, och des...
    https://stm.fi/sv/utkomststod
  93. The Ministry The Ministry of Social Affairs and Health (MSAH) is one of the 12 ministries in the Government. The Ministry's tasks promote the good health and functional capacity of people promote healthy living and working environments secure suff...
    https://stm.fi/en/ministry
  94. 5.1.2026 | ​​​​​​​ Social- och hälsovårdsministeriet inleder ett projekt för att uppdatera handboken om säker läkemedelsbehandling. Syftet med handboken är att stärka informationsstyrningen vid upprättandet av planerna för läkemedelsbehandlingen och säkerställandet av säkerheten inom läkemedelsbehandlingen.  
    https://stm.fi/sv/-/handboken-om-saker-lakemedelsbehandling-uppdateras
  95. 9.4.2020 | The Ministry of Social Affairs and Health has decided to extend the validity of a decision made under section 87 of the Emergency Powers Act. The aim is to ensure the availability of medicinal products and the functioning of the distribution chain in Finland in the emergency conditions caused by the novel coronavirus. The content of the decision is the same as of the decision issued by the Ministry on 19 March 2020.
    https://stm.fi/en/-/stm-n-paatoksilla-varmistetaan-laakevalmisteiden-saatavuutta-ja-jakeluketjun-toimivuutta
  96. Stöd för barn och unga som insjuknat i narkolepsi och deras familjer 1. På vilket sätt har man erbjudit stöd åt familjer till barn med narkolepsi? Evenemang och kontakt Vid social- och hälsovårdsministeriet började man vidta nödvändiga och eventue...
    https://stm.fi/sv/narkolepsi
  97. 13.11.2025 | A national collaboration model is being proposed for Finland to strengthen collaboration among key stakeholders in clinical research and make it easier for patients to access new treatments. The FinTrials collaboration model also aims to strengthen Finland’s position as an attractive country for clinical trials and increase investments in the sector. The proposal was made by the Finnish Innovation Fund Sitra at the request of the Ministry of Social Affairs and Health.
    https://stm.fi/en/-/a-national-collaboration-model-is-proposed-for-clinical-trials-facilitating-patient-access-to-trials-and-bringing-growth-to-finland
  98. Ansökan om statsunderstöd år 2022 Statsunderstöd för 2022 är listade nedan. Avslutade ansökan om statsunderstöd Statsunderstöd för vissa merkostnader som den offentliga social- och hälsovårdens orsakas på grund av covid-19-pandemin Ansökningstiden...
    https://stm.fi/sv/ansokan-om-statsunderstod-ar-2022
  99. fi sv Ny lagstiftning om funktionshinderservice Den nya lagen om funktionshinderservice (675/2023) trädde i kraft den 1 januari 2025. Lagen innefattar en övergångsperiod på tre år. Lagens tillämpningsområde har preciserats, och ändringarna i lagen...
    https://stm.fi/sv/lagen-om-funktionshinderservice
  100. 5.12.2025 | 1 Classified as ECDC NORMAL Appendix 10 - Country follow-up to ECDC PHEPA recommendations Following the PHEPA mission conducted in your country, the final ECDC assessment report includes a series of recommendations aiming at supporting your countr...
    https://stm.fi/documents/1271139/231157712/National_Action_Plan_2025_Finland_follow_up_ECDC.pdf/800f16d0-fa2a-cba1-acfe-97e6f89a07df?t=1764936667375